Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Eisai acquires MGI Pharma
As a result of this acquisition, MGI Pharma becomes a wholly-owned subsidiary of Eisai Corporation of North America. At the effective time of the merger, all outstanding shares
As a result of this acquisition, MGI Pharma becomes a wholly-owned subsidiary of Eisai Corporation of North America. At the effective time of the merger, all outstanding shares
Champix is claimed to be Japan’s first oral smoking cessation aid developed for smoking cessation treatment. Current ‘nicotine replacement therapy’ relieves withdrawal symptoms associated with smoking cessation by
The transaction also includes five-year warrants to purchase 3.5 million shares of common stock at an exercise price of $3 per share. The transaction is expected to raise
The study has confirmed that the catheter provides highly acceptable flow rates at modest negative pressure without deterioration in flow rate over seven weeks of use, even with
The pivotal study, Serene, investigated patients suffering from rheumatoid arthritis (RA) who had an inadequate response to methotrexate (MTX) therapy, a commonly used RA drug. The study successfully
The $25 million facility more than doubles the previous MDS Phase I capacity in Phoenix to 420 total beds to meet the growing needs of its pharmaceutical and
Under the terms of the settlement, Glaxo has agreed not to assert its patent against Cypress’s new alcohol-free formulation of its generic ranitidine oral syrup. Cypress expects to
Douglass Simpson, Corgenix’s president and CEO, said: “In the quarter ended December 31, 2007, we continued to add important new customers in the US and internationally, and we
In addition, the FDA notified the company that it will convene an advisory committee panel on May 6, 2008, to consider this application. Included in the Fentora (fentanyl
The defendants named in the lawsuit include Dr Reddy’s Laboratories Limited, Genpharm, Interpharm, Mylan Pharmaceuticals, Ranbaxy Laboratories, Sun India Pharmaceutical Industries, and related companies and subsidiaries thereof. The